Biocept Stock

Biocept Market capitalization

The The market capitalization of Biocept (BIOCQ) as of Mar 4, 2026 is 57 USD. In the previous year, The market capitalization was 57.29 USD — a change of -0.5% (lower).

Market capitalization

57USD

YoY

-0.5%

Last updated: Mar 4, 2026

In 2026, Biocept's market cap stood at 57 USD, a -0.5% increase from the 57.29 USD market cap in the previous year.

The Biocept Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market Capitalization (M USD)
Date
Market Capitalization (M USD)
Jan 1, 2011
0 base
Jan 1, 2012
0 base
Jan 1, 2013
0 base
Jan 1, 2014
0 base
Jan 1, 2015
0 base
Jan 1, 2016
0 base
Jan 1, 2017
0 base
Jan 1, 2018
18.74 base
Jan 1, 2019
20.59 base
Jan 1, 2020
57.7 base
Jan 1, 2021
66.97 base
Jan 1, 2022
24.93 base
YEARMarket Capitalization (M USD)
2022 24.93
2021 66.97
2020 57.7
2019 20.59
2018 18.74
2017 -
2016 -
2015 -
2014 -
2013 -
2012 -
2011 -

Unlock the full history with 30+ years of data and forecast estimates.

Unlock all data — PRO
API Docs Get API Key

Biocept Stock analysis

What does Biocept do? Biocept is one of the most popular companies on Eulerpool.com.

Market capitalization Details

Exploring Biocept's Market Capitalization

Biocept's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Biocept's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Biocept's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Biocept’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Biocept stock

The market capitalization of Biocept amounted to 57.29 USD 57

Valuation — Biocept

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

All Key Metrics — Biocept